The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
ExcelTaq 2X Q-PCR Master Mix (SYBR, ROX), 200 Rxn – TQ1110
ExcelTaq ™ 2X Q-PCR Master Mix (SYBR, ROX) is a...
ExcelRT One-Step RT-qPCR Kit (TaqMan, ROX), 200 Rxn – RQ2110
The ExcelRT One-Step RT-qPCR kit (TaqMan, ROX) is designed for...
WATER ULTRA PURE 500 ML
ultrapure cell culture grade water free of DNases, RNases, proteases...
PANAMutyper™ R EGFR
To screen EGFR+ patients and determine their response to various...





